Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)

SHA:605033 Revenue

Shaanxi Meibang Pharmaceutical Group had revenue of 218.60M CNY in the quarter ending June 30, 2026, with 11.58% growth. This brings the company's revenue in the last twelve months to 981.56M, up 13.97% year-over-year. In the year 2025, Shaanxi Meibang Pharmaceutical Group had annual revenue of 911.95M with 2.98% growth.

• Revenue (ttm): 981.56M
• Revenue Growth: +13.97%
• P/S Ratio: 2.64
• Revenue / Employee: 878.75K
• Employees: 1,117
• Market Cap: 2.59B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	911.95M	26.42M	2.98%
Dec 31, 2024	885.53M	186.50M	26.68%
Dec 31, 2023	699.03M	-207.02M	-22.85%
Dec 31, 2022	906.05M	63.56M	7.54%
Dec 31, 2021	842.49M	273.97M	48.19%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error